Aerosol Treatments During COVID-19 Pandemic: A Personal Journey

J Aerosol Med Pulm Drug Deliv. 2020 Oct;33(5):288-289. doi: 10.1089/jamp.2020.1632. Epub 2020 Jul 22.

Author

Israel Amirav^{1

2

3}

Affiliations

¹ Pulmonary Unit, Dana Dwek Children's Hospital, Tel Aviv, Israel.
² Respirology Division, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ University of Alberta, Edmonton, Canada.

PMID: 32723207
DOI: 10.1089/jamp.2020.1632

No abstract available

Publication types

Letter

MeSH terms

Administration, Inhalation
Aerosols
Betacoronavirus / pathogenicity*
COVID-19
Coronavirus Infections / diagnosis
Coronavirus Infections / epidemiology
Coronavirus Infections / transmission
Coronavirus Infections / virology*
Host-Pathogen Interactions
Humans
Metered Dose Inhalers
Nebulizers and Vaporizers*
Pandemics
Patient Safety
Pneumonia, Viral / diagnosis
Pneumonia, Viral / epidemiology
Pneumonia, Viral / transmission
Pneumonia, Viral / virology*
Public Health
Respiratory System Agents / administration & dosage*
Respiratory System Agents / adverse effects
SARS-CoV-2

Substances

Aerosols
Respiratory System Agents